We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HES
301
DELISTED
Hess
HES
$3.76M 0.07%
78,027
-35,798
-31% -$1.9M
CALA
302
DELISTED
Calithera Biosciences, Inc
CALA
$3.76M 0.07%
16,260
+6,750
+71% +$1.17M
PANW icon
303
Palo Alto Networks
PANW
$264B
$3.74M 0.07%
199,236
+85,140
+75% +$1.9M
JWN
304
DELISTED
Nordstrom
JWN
$3.74M 0.07%
+80,283
New +$3.59M
LXRX icon
305
Lexicon Pharmaceuticals
LXRX
$1.02B
$3.73M 0.07%
260,000
+65,000
+33% +$964K
BLK icon
306
Blackrock
BLK
$164B
$3.73M 0.07%
9,717
+3,569
+58% +$1.37M
EBAY icon
307
eBay
EBAY
$48.6B
$3.71M 0.07%
110,416
+17,049
+18% +$554K
SWK icon
308
Stanley Black & Decker
SWK
$14.2B
$3.71M 0.07%
27,897
+5,899
+27% +$740K
IRBT
309
DELISTED
iRobot
IRBT
$3.7M 0.07%
55,964
+31,958
+133% +$1.89M
F icon
310
Ford
F
$57.3B
$3.69M 0.07%
317,171
+49,848
+19% +$619K
TGTX icon
311
TG Therapeutics
TGTX
$8.58B
$3.67M 0.07%
315,000
+90,000
+40% +$646K
ZLTQ
312
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
$3.67M 0.07%
+66,000
New +$3.31M
WOOF
313
DELISTED
VCA Inc.
WOOF
$3.66M 0.07%
40,000
-84,019
-68% -$7.54M
WM icon
314
Waste Management
WM
$95.9B
$3.65M 0.07%
50,080
+1,301
+3% +$92.8K
ANDV
315
DELISTED
Andeavor
ANDV
$3.64M 0.07%
44,852
+28,405
+173% +$2.38M
VYX icon
316
NCR Voyix
VYX
$1.06B
$3.63M 0.07%
+129,530
New +$3.55M
LH icon
317
Labcorp
LH
$24.3B
$3.62M 0.07%
29,361
-10,157
-26% -$1.2M
MRSH
318
Marsh
MRSH
$86.3B
$3.62M 0.07%
48,948
+5,288
+12% +$378K
RIGL icon
319
Rigel Pharmaceuticals
RIGL
$680M
$3.59M 0.07%
108,500
+47,000
+76% +$1.2M
SLAB icon
320
Silicon Laboratories
SLAB
$7.15B
$3.58M 0.07%
48,651
+25,972
+115% +$1.82M
TPR icon
321
Tapestry
TPR
$28.8B
$3.56M 0.07%
86,260
+71,156
+471% +$2.68M
NOC icon
322
Northrop Grumman
NOC
$77B
$3.48M 0.07%
14,638
+2,071
+16% +$492K
ALNY icon
323
Alnylam Pharmaceuticals
ALNY
$36.3B
$3.43M 0.07%
67,000
+7,000
+12% +$324K
MTB icon
324
M&T Bank
MTB
$36.2B
$3.43M 0.07%
22,141
+4,461
+25% +$722K
TMUS icon
325
T-Mobile US
TMUS
$193B
$3.4M 0.07%
52,696
-11,061
-17% -$680K
11 12
13
14 15

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.